U-Chart Analysis:Renascience Inc.:4889

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Renascience Inc. Go to web site 4889 Medicals 東証グロース March 1, 2000 2021.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Renascience Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Renascience Inc. Balance Sheet 2024年3月期 Renascience Inc. Balance Sheet 2023年3月期 Renascience Inc. Balance Sheet 2022年3月期 Renascience Inc. Balance Sheet 2021年3月期 Renascience Inc. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents 2,027 2,212 2,387 1,026 981
Other Current AssetsHelp 60 55 42 17 7
Tangible Fixed AssetsHelp 0 4 4 4 3
Intangible Fixed AssetHelp 0 0 0 13 15
Investments and OthersHelp 2 3 6 7 6
Total AssetsHelp 2,089 2,275 2,438 1,067 1,013
Total Current LiabilitiesHelp 126 100 38 29 11
Total Long-term LiabilitiesHelp 356 310 199 476 380
Shareholder's EquityHelp 1,607 1,865 2,201 562 622
Total LiabilitiesHelp 2,089 2,275 2,438 1,067 1,013

Renascience Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Renascience Inc. Profit and Loss Account 2024年3月期 Renascience Inc. Profit and Loss Account 2023年3月期 Renascience Inc. Profit and Loss Account 2022年3月期 Renascience Inc. Profit and Loss Account 2021年3月期 Renascience Inc. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales 194 101 139 210 72
Total Sales 194 101 139 210 72
Cost of SalesHelp 29 0 58 30 20
Other Costs and RevenueHelp 424 436 335 280 236
Total CostsHelp 452 436 394 310 256
Net RevenueHelp 166 100 81 180 52
Earnings Before TaxHelp -256 -334 -253 -100 -184
Net IncomeHelp -258 -336 -254 -100 -184
Net Income -258 -336 -254 -100 -184

Renascience Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Renascience Inc. Cash Flow Statement 2024年3月期 Renascience Inc. Cash Flow Statement 2023年3月期 Renascience Inc. Cash Flow Statement 2022年3月期 Renascience Inc. Cash Flow Statement 2021年3月期 Renascience Inc. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help -231 -285 -230 -89 -178
Investing Cash Flow(ICF)Help -2 0 -0 -2 -381
Financing Cash FlowHelp 47 110 1,592 136 380
Exchange Difference of Cash and Cash EquivalentsHelp -0 0 0 -0 0
Net Increase and Decrease in Cash and Cash Equivalentsn -186 -174 1,361 45 -179

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Renascience Inc.

Company where related level is highHelp

MUROMACHI CHEMICALS INC.
Otsuka Holdings Co.,Ltd.
MIZUHO MEDY CO.,LTD.
RaQualia Pharma Inc.
Daito Pharmaceutical Co.,Ltd.
PeptiDream Inc.
MEDICAL & BIOLOGICAL LABORATORIES CO.
D.Western Therapeutics Institute, Inc.
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
DAIICHI SANKYO COMPANY, LIMITED